Neuroprotective Effects of Methylene Blue In Vivo and In Vitro

Area of Science:

• Neuroscience
• Neurobiology
• Traumatic Brain Injury Research

Background:

• Traumatic brain injury (TBI) affecting the sensorimotor cortex disrupts contralateral limb function.
• Understanding the mechanisms of neuronal damage and developing effective treatments for TBI is crucial.

Purpose of the Study:

• To investigate the neuroprotective effects of methylene blue (MB) in a rodent model of focal TBI.
• To evaluate MB's ability to mitigate functional deficits and reduce neuronal death.

Main Methods:

• Induction of focal unilateral TBI in the sensorimotor cortex of rats.
• Intravenous administration of methylene blue (1 mg/kg) before or after TBI.
• Assessment of functional recovery in contralateral limbs.
• In vitro studies using cultured neurons exposed to paraquat or zinc ions to assess MB's protective effects on mitochondria.

Main Results:

• Methylene blue administration significantly attenuated functional disorders in the affected limbs.
• MB treatment, whether pre-emptive or post-injury, reduced the severity of functional impairments.
• In vitro, methylene blue demonstrated efficacy in reducing neuronal death induced by paraquat and zinc ions, known mitochondrial toxins.

Conclusions:

• Methylene blue exhibits significant therapeutic potential in mitigating functional deficits associated with sensorimotor cortex TBI.
• MB's neuroprotective action may be linked to its ability to counteract mitochondrial dysfunction and subsequent neuronal death.